Detalhe da pesquisa
1.
Impact of tocilizumab on anti-CD19 chimeric antigen receptor T-cell therapy in B-cell acute lymphoblastic leukemia.
Cancer;
2024 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38578977
2.
Chinese expert consensus on integrated case management by a multidisciplinary team in CAR-T cell therapy for lymphoma.
Chin Med J (Engl);
2024 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38570196
3.
Phase II study of novel orally PI3Kα/δ inhibitor TQ-B3525 in relapsed and/or refractory follicular lymphoma.
Signal Transduct Target Ther;
9(1): 99, 2024 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38627366
4.
The DNA damage-independent ATM signalling maintains CBP/DOT1L axis in MLL rearranged acute myeloid leukaemia.
Oncogene;
2024 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38671157
5.
Indicators describing the tumor lesion aggregation and dissemination and their impact on the prognosis of patients with diffuse large B cell lymphoma receiving chimeric antigen receptor T cell therapy.
Cancer Med;
13(6): e6991, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38506226
6.
Tumor-derived exosomes induce initial activation by exosomal CD19 antigen but impair the function of CD19-specific CAR T-cells via TGF-ß signaling.
Front Med;
18(1): 128-146, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37870681
7.
Serine and Arginine-Rich Splicing Factor 3 Promotes the Activation of Quiescent Mouse Neural Stem Cells.
Stem Cells Dev;
33(3-4): 79-88, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38115601
8.
CAR-Aptamers Enable Traceless Enrichment and Monitoring of CAR-Positive Cells and Overcome Tumor Immune Escape.
Adv Sci (Weinh);
11(10): e2305566, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38148412
9.
A combinatorial therapeutic approach to enhance FLT3-ITD AML treatment.
Cell Rep Med;
4(11): 101286, 2023 11 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37951217
10.
Outcomes and risk factors of SARS-CoV-2 omicron variant in B-cell lymphoma patients following CD19 targeted CAR-T therapy.
Cancer Med;
12(22): 20838-20846, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37962082
11.
Anti-CD79b/CD3 bispecific antibody combined with CAR19-T cells for B-cell lymphoma treatment.
Cancer Immunol Immunother;
72(11): 3739-3753, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37707586
12.
Decitabine in patients with myelodysplastic syndromes: A multi-center, open-label, dose comparison trial.
Cancer Med;
12(13): 13885-13893, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37350499
13.
Case report: Circulating tumor DNA technology displays temporal and spatial heterogeneity in Waldenström macroglobulinemia during treatment with BTK inhibitors.
Pathol Oncol Res;
29: 1611070, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37151353
14.
Effect of arsenic trioxide plus etoposide, solumedrol, highdose cytarabine and cisplatin chemotherapy on the treatment of relapsed or ref7ractory ALK+ anaplastic large cell lymphoma.
Oncol Lett;
25(6): 268, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37216160
15.
2022 Chinese expert consensus and guidelines on clinical management of toxicity in anti-CD19 chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma.
Cancer Biol Med;
20(2)2023 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36861439
16.
Challenges and optimal strategies of CAR T therapy for hematological malignancies.
Chin Med J (Engl);
136(3): 269-279, 2023 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36848181
17.
Strategies to optimize chimeric antigen receptor T-cell therapy in hematologic malignancies: Chinese experience.
Haematologica;
108(8): 2011-2028, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36794504
18.
The Landscape of Cytogenetic Aberrations in Light-Chain Amyloidosis with or without Coexistent Multiple Myeloma.
J Clin Med;
12(4)2023 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36836158
19.
Prognostic impact of peripheral eosinophil counts in patients with diffuse large B-cell lymphoma receiving chimeric antigen receptor T-cell therapy.
Cytotherapy;
25(6): 573-577, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36456447
20.
Regional empowerment through decentralised governance under a centralised regulatory system facilitates the development of cellular therapy in China.
Lancet Haematol;
9(12): e942-e954, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36455609